DiNA-P: Diabetes Nutrition Algorithm - Prediabetes

Sponsor
German Institute of Human Nutrition (Other)
Overall Status
Unknown status
CT.gov ID
NCT02609243
Collaborator
German Diabetes Center (Other)
250
2
4
101
125
1.2

Study Details

Study Description

Brief Summary

Prediabetes, defined by either impaired fasting glucose and/or impaired glucose tolerance, is a known high-risk condition predisposing to future diabetes mellitus type 2. Strategies to prevent progression from prediabetes to diabetes have been widely studied, however, without striking long-term effects of any kind of intervention (pharmacological, behavioral...). The investigators therefore investigate certain nutritional approaches concerning nutrient content and favorable food components, targeting metabolic improvement.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: dietary consulting
N/A

Detailed Description

Prediabetes, defined by either impaired fasting glucose and/or impaired glucose tolerance, is a known high-risk condition predisposing to future diabetes mellitus type 2. Strategies to prevent progression from prediabetes to diabetes have been widely studied, however, without striking long-term effects of any kind of intervention (pharmacological, behavioral...). The investigators therefore investigate certain nutritional approaches concerning nutrient content and favorable food components, targeting metabolic improvement.

The main comparison will assess differences in metabolic outcome due to low-carb or low-fat dietary intervention in short- and long-term design.

Additionally, the role of PUFA will be assessed during long-term intervention to achieve better maintenance of metabolic improvements from the first study phase.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Diabetes Nutrition Algorithm - Prediabetes (Dietary Strategies in the Prevention of Diabetes Mellitus Type 2 in a High-risk Cohort)
Actual Study Start Date :
Jul 1, 2013
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: intensive consulting, conventional diet

subjects receive 16 units of nutritional consulting, first 3 weeks of intervention phase are designed as a conventional hypocaloric low-fat diet referring to DGE guidelines (below 30 % fat), followed by 11 months of isocaloric-to-moderate-hypocaloric low-fat diet (below 30 kcal% fat ) - dietary intervention without supplement

Behavioral: dietary consulting
dietary consulting implies specific dietary advice based on pre-interventional self-report regarding food intake; consulting focuses on nutrient content, calory intake, weight loss; with regard to randomisation consulting intensity and content varies
Other Names:
  • dietary intervention without supplement
  • Active Comparator: conventional consulting, low-carb diet

    subjects receive 8 units of nutritional consulting, first 3 weeks of intervention phase are designed as a very-low calory ketogenic (low-carb) diet (< 40 g CH / day), following 11 months are restricted to not more than 40 % energy intake by carbohydrates under isocaloric-to-moderate-hypocaloric conditions - dietary intervention without supplement

    Behavioral: dietary consulting
    dietary consulting implies specific dietary advice based on pre-interventional self-report regarding food intake; consulting focuses on nutrient content, calory intake, weight loss; with regard to randomisation consulting intensity and content varies
    Other Names:
  • dietary intervention without supplement
  • Active Comparator: conventional consulting, conventional diet

    subjects receive 8 units of nutritional consulting, first 3 weeks of intervention phase are designed as a conventional hypocaloric low-fat diet referring to DGE guidelines (below 30 % fat), followed by 11 months of isocaloric-to-moderate-hypocaloric low-fat diet (below 30 kcal% fat) - dietary intervention without supplement

    Behavioral: dietary consulting
    dietary consulting implies specific dietary advice based on pre-interventional self-report regarding food intake; consulting focuses on nutrient content, calory intake, weight loss; with regard to randomisation consulting intensity and content varies
    Other Names:
  • dietary intervention without supplement
  • Active Comparator: intensive consulting, low-carb diet

    subjects receive 16 units of nutritional consulting, first 3 weeks of intervention phase are designed as a very-low calory ketogenic (low-carb) diet (< 40 g CH / day), following 11 months are restricted to not more than 40 % energy intake by carbohydrates under isocaloric-to-moderate-hypocaloric conditions - dietary intervention without supplement

    Behavioral: dietary consulting
    dietary consulting implies specific dietary advice based on pre-interventional self-report regarding food intake; consulting focuses on nutrient content, calory intake, weight loss; with regard to randomisation consulting intensity and content varies
    Other Names:
  • dietary intervention without supplement
  • Outcome Measures

    Primary Outcome Measures

    1. change in postprandial glycaemia (2h plasma glucose level of the 75 g oral glucose tolerance test (OGTT)) [3 weeks, 6 months, 1 year, 3 years]

    2. change in hepatic fat content confirmed by proton magnetic resonance spectroscopy by 3 T MR imaging [3 weeks, 6 months, 1 year, 3 years]

    Secondary Outcome Measures

    1. change in insulin sensitivity confirmed by 75 g oral glucose tolerance test (OGTT) [3 weeks, 6 months, 1 year, 3 years]

      insulin resistance is calculated as follows: Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0) ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))

    2. change in insulin secretion confirmed by 75 g oral glucose tolerance test (OGTT) [3 weeks, 6 months, 1 year, 3 years]

      insulin resistance is calculated as follows: Insulinogenic index (IGI) = (I30 - I0) / (G30 - G0) ISIest= 10000/²√ ((G0 x I0) x ((G0+G30+G60+G90+G120)/5) x ((I0+I30+I60+I90+I120)/5))

    3. change in distribution of body fat confirmed by MR-Imaging by 3 T whole body imager [3 weeks, 6 months, 1 year, 3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • impaired fasting glucose (IFG) fasting blood glucose 100-126 mg/dl

    and/or

    • impaired glucose tolerance (IGT) 75 g OGTT 120 minutes: 140-200 mg/dl
    Exclusion Criteria:
    • current pregnancy or breastfeeding

    • BMI > 45 kg/m²

    • Diabetes mellitus Typ 1 or 2

    • serious disease e.g symptomatic coronary heart disease

    • serious symptomatic malignant disease (weight loss > 10% within the last 6 month)

    • severe liver or kidney disease ( an increase in transaminases > 3 times than the upper limit of the standardized range, GFR < 50 ml/min/1,73m²)

    • systemic infection (CRP > 1 mg/dl)

    • severe mental illness

    • drug abuse

    • treatment with steroids

    • potentially incompliant subjects

    • exclusion criteria for magnetic resonance tomography

    • any kind of metal in or on the body: cardiac pacemakers prosthetic heart valves metal prosthesis magnetic implanted metallic parts contraceptive coil metal fragments/ grenade shrapnel fixed braces acupuncture needles insulin pump intraport etc. Field strength > 3 Tesla further tattoos, permanent make-up

    • persons with limited thermosensory or heightened sensitivity to heating

    • persons where cardiovascular disease cannot be ruled out by examination

    • persons with heightened sensitivity to loud noise or diseases of the ear

    • used closed whole body scanner: claustrophobia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 German Institut for Human Nutrition; Department for Clinical Nutrition Bergholz-Rehbrücke Brandenburg Germany 14458
    2 German Institute for Human Nutrition, Department for Clinical Nutrition Berlin Germany 12203

    Sponsors and Collaborators

    • German Institute of Human Nutrition
    • German Diabetes Center

    Investigators

    • Principal Investigator: Andreas FH Pfeiffer, Prof. Dr., German Institute of Human Nutrition

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Prof. Dr. med. Andreas F. H. Pfeiffer, Director / Department for Clinical Nutrition, German Institute of Human Nutrition
    ClinicalTrials.gov Identifier:
    NCT02609243
    Other Study ID Numbers:
    • DiNA-P
    First Posted:
    Nov 20, 2015
    Last Update Posted:
    Jun 24, 2020
    Last Verified:
    Jun 1, 2020
    Keywords provided by Prof. Dr. med. Andreas F. H. Pfeiffer, Director / Department for Clinical Nutrition, German Institute of Human Nutrition
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 24, 2020